FdaApplication
ANDA 202103
Identifiers
- fda_app_no: ANDA202103
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | ANDA |
| approval_date | 2016-06-10 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DASATINIB | DASATINIB | 20MG | TABLET;ORAL |
| DASATINIB | DASATINIB | 70MG | TABLET;ORAL |
| DASATINIB | DASATINIB | 50MG | TABLET;ORAL |
| DASATINIB | DASATINIB | 100MG | TABLET;ORAL |
4 products